Myocardin and Prx1 Contribute to Angiotensin II-Induced Expression of Smooth Muscle α-Actin

Circulation Research

Volumn 94, Issue 8, 2004, Pages 1075-1082

  Yoshida, Tadashi ^a   Hoofnagle, Mark H ^a   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiotensin II; CArG element; Serum response factor; Smooth muscle cells; Transcriptional coactivator

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; GENE PRODUCT; HOMEODOMAIN PROTEIN; MESSENGER RNA; MYOCARDIN; PROTEIN PRX1; SERUM RESPONSE FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER;

ACTINS; ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, REPORTER; HOMEODOMAIN PROTEINS; HYPERTROPHY; MICE; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; RNA, SMALL INTERFERING; SERUM RESPONSE FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 2342510310     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000125622.46280.95     Document Type: Article

References (32)

1. Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A, the Groupe de Prévention Cardio-vasculaire en Médecine du Travail. Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension. 1993;22:111-118.
2. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res. 1985;56:525-536.
3. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat: role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res. 1982;51:280-289.
4. Lichtenstein AH, Brecher P, Chobanian AV. Effects of deoxycorticosterone-salt hypertension on cell ploidy in the rat aorta. Hypertension. 1986;8(pt 2):II50-II54.
5. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
6. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
7. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
8. Rao GN, Griendling KK, Frederickson RM, Sonenberg N, Alexander RW. Angiotensin II induces phosphorylation of eukaryotic protein synthesis initiation factor 4E in vascular smooth muscle cells. J Biol Chem. 1994;269:7180-7184.
9. Hershey JC, Hautmann M, Thompson MM, Rothblum LI, Haystead TAJ, Owens GK. Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor. J Biol Chem. 1995;270:25096-25101.
10. Turla MB, Thompson MM, Corjay MH, Owens GK. Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells: evidence for selective increases in smooth muscle isoactin expression. Circ Res. 1991;68:288-299.
11. Hautmann MB, Thompson MM, Swartz EA, Olson EN, Owens GK. Angiotensin II-induced stimulation of smooth muscle α-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res. 1997;81:600-610.
12. Mack CP, Owens GK. Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ Res. 1999;84:852-861.
13. Norman C, Runswick M, Pollock R, Treisman R. Isolation and property of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 1988;55:989-1003.
14. Grueneberg DA, Natesan S, Alexandre C, Gilman MZ. Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science. 1992;257:1089-1095.
15. Wang D-Z, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001;105:851-862.
16. Yoshida T, Sinha S, Dandré F, Wamhoff BR, Hoofnagle MH, Kremer BE, Wang D-Z, Olson EN, Owens GK. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res. 2003;92:856-864.
17. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W, Lu MM, Owens GK, Parmacek MS. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol. 2003;23:2425-2437.
18. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002;34:1345-1356.
19. Wang Z, Wang D-Z, Pipes GCT, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A. 2003;100:7129-7134.
20. Li S, Wang D-Z, Wang Z, Richardson JA, Olson EN. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci U S A. 2003;100:9366-9370.
21. Yoshida T, Yoshino J, Hayashi M, Saruta T. Identification of a renal proximal tubular cell-specific enhancer in the mouse 25- hydroxyvitamin D 1α-hydroxylase gene. J Am Soc Nephrol. 2002;13:1455-1463.
22. Putten VV, Li X, Maselli J, Nemenoff RA. Regulation of smooth muscle α-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ Res. 1994;75:1126-1130.
23. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Chem. 1997;272:10948-10956.
24. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593.
25. 6GG elements with c-fos serum response elements results in increased basal expression but relaxed SM cell specificity and reduced angiotensin II inducibility. J Biol Chem. 1998;273:8398-8406.
26. Martin JF, Bradley A, Olson EN. The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev. 1995;9:1237-1249.
27. Bergwerff M, Gittenberger-de Groot AC, Wisse LJ, DeRuiter MC, Wessels A, Martin JF, Olson EN, Kern MJ. Loss of function of the Prx1 and Prx2 homeobox genes alters architecture of the great elastic arteries and ductus arteriosus. Virchows Arch. 2000;436:12-19.
28. Mack CP, Thompson MM, Lawrenz-Smith S, Owens GK. Smooth muscle α-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res. 2000;86:221-232.
29. Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, Inagami T. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension. 2000;35(pt2):313-318.
30. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem. 2001;276:341-347.
31. Miralles F, Posern G, Zaromytidou A-I, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003;113:329-342.
32. Liu HW, Halayko AJ, Fernandes DJ, Harmon GS, McCauley JA, Kocieniewski P, McConville J, Fu Y, Forsythe SM, Kogut P, Bellam S, Dowell M, Churchill J, Lesso H, Kassiri K, Mitchell RW, Hershenson MB, Camoretti-Mercado B, Solway J. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol. 2003;29:39-43.